CONCORD DRUGS
Back to Balance Sheet
|
CONCORD DRUGS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Capital Work in Progress | ₹2.00 Cr | ₹1.63 Cr | ₹0.92 Cr | ₹0.55 Cr |
What is the latest Capital Work in Progress ratio of CONCORD DRUGS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹2.00 Cr |
| Mar2024 | ₹1.63 Cr |
| Mar2023 | ₹0.92 Cr |
| Mar2022 | ₹0.55 Cr |
How is Capital Work in Progress of CONCORD DRUGS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.00 Cr | 22.44 | |
| Mar2024 | ₹1.63 Cr | 77.09 | |
| Mar2023 | ₹0.92 Cr | 66.25 | |
| Mar2022 | ₹0.55 Cr | - | |
Compare Capital Work in Progress of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹105.2 Cr | 2% | 12.9% | 22.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | 2% |
12.9% |
22.6% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses